New CAR t therapy aims to control myeloma early
Disease control
Recruiting now
This study tests a new treatment called BMS-986453, a type of CAR T cell therapy that targets two proteins on myeloma cells. It is for people who have been recently diagnosed with multiple myeloma and are not planning to have a stem cell transplant. The goal is to see if the trea…
Phase: PHASE1 • Sponsor: Susan Bal • Aim: Disease control
Last updated May 17, 2026 02:00 UTC